Discovery and development of a potent and highly selective WEE1 inhibitor IMP7068

被引:2
|
作者
Cai, Sui Xiong
Ma, Ning
Wang, Xiaozhu
Jiang, Yangzhen
Zhang, Hongxia
Guo, Mingchuan
Zhou, Ruiyu
Tian, Ye Edward
机构
关键词
D O I
10.1158/1538-7445.AM2023-3091
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3091
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Advanced Design, Synthesis, and Evaluation of Highly Selective Wee1 Inhibitors: Enhancing Pharmacokinetics and Antitumor Efficacy
    Wang, Yong
    Xu, Chunyue
    Jiang, Yiqing
    Tu, Zhenlin
    Yan, Jingxue
    Guo, Leyi
    Dong, Chao
    Liu, Jiaqi
    Yang, Xiulong
    Wang, Ziyi
    Lu, Tao
    Feng, Jie
    Chen, Yadong
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (12) : 9927 - 9949
  • [32] MK1775, a selective Wee1 inhibitor shows antitumor activity against sarcoma cells
    Kreahling, Jenny M.
    Foroutan, Parastou
    Gemmer, Jennifer Y.
    Martinez, Gary
    Reed, Damon
    Letson, Douglas
    Bui, Marilyn
    Gillies, Rober J.
    Altiok, Boner
    CANCER RESEARCH, 2012, 72
  • [33] Discovery of pyrrolo[2,3-d]pyrimidine-based molecules as a Wee1 inhibitor template
    Chen, Changjun
    Wang, Yeliu
    Hu, Min-Qi
    Li, Hongjuan
    Chen, Xi
    Qiang, Gan
    Sun, Yinghui
    Zhu, Yan
    Li, Binghui
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 75
  • [34] Discovery of potential WEE1 inhibitors via hybrid virtual screening
    Jin, Tingting
    Xu, Wei
    Chen, Roufen
    Shen, Liteng
    Gao, Jian
    Xu, Lei
    Chi, Xinglong
    Lin, Nengming
    Zhou, Lixin
    Shen, Zheyuan
    Zhang, Bo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [35] Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1
    Sabat, Mark
    Carney, Daniel W.
    Hernandez-Torres, Gloria
    Gibson, Tony S.
    Balakrishna, Deepika
    Zou, Hua
    Xu, Rui
    Chen, Chien-Hung
    de Jong, Ron
    Dougan, Douglas R.
    Qin, Ling
    Bigi-Botterill, Simone V.
    Chambers, Alison
    Miura, Joanne
    Johnson, Lucas K.
    Ermolieff, Jacques
    Johns, Deidre
    Selimkhanov, Jangir
    Kwok, Lily
    Dement, Kevin
    Proffitt, Chris
    Vu, Phong
    Lindsey, Erick A.
    Ivetac, Tony
    Jennings, Andy
    Wang, Haixia
    Manam, Padma
    Santos, Cipriano
    Fullenwider, Cody
    Manohar, Rohan
    Flick, Andrew C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (12) : 10306 - 10320
  • [36] Discovery of a highly potent and in vivo efficacious Bcl-xL selective inhibitor
    Tao, Zhi-Fu
    Wang, Le
    Nimmer, Paul M.
    Boghaert, Erwin R.
    Chen, Jun
    Hasvold, Lisa A.
    Jin, Sha
    Kovar, Peter J.
    Mitten, Michael J.
    Oleksijew, Anatol
    Park, Chang H.
    Petros, Andrew M.
    Phillips, Darren C.
    Smith, Morey
    Tahir, Stephen X.
    Tse, Chris
    Wang, Xilu
    Xiao, Yu
    Zhang, Haichao
    Deshayes, Kurt
    Fairbrother, Wayne J.
    Flygare, John A.
    Hymowitz, Sarah G.
    Koehler, Michael
    Ndubaku, Chudi
    Rawson, Tom
    Zobel, Kerry
    Colman, Peter M.
    Czabotar, Peter E.
    Huang, David C. S.
    Lessene, Guillaume
    Sleebs, Brad E.
    Watson, Keith G.
    Leverson, Joel D.
    Elmore, Steven W.
    Souers, Andrew J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [37] Discovery of BMS-962212 a highly potent, selective inhibitor of coagulation FXIa
    Pinto, Donald
    Orwat, Michael
    Smith, Leon, II
    Shrivastava, Shefali
    Quan, Mimi
    Lam, Patrick
    Rossi, Karen
    Apedo, Atsu
    Bozarth, Jeffrey
    Wu, Yiming
    Zheng, Joanna
    Xin, Baomin
    Toussaint, Nathalie
    Stetsko, Paul
    Gudmundsson, Olafur
    Crain, Earl
    Wong, Pancras
    Lou, Zhen
    Harper, Timothy
    Chacko, Silvi
    Myers, Joseph
    Sheriff, Steven
    Zhang, Huiping
    Hou, Xiaoping
    Mathur, Arvind
    Seiffert, Dietmar
    Luettgen, Joseph
    Wexler, Ruth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [38] Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor
    Shimizu, Kazuo
    Fujikura, Hideki
    Fushimi, Nobuhiko
    Nishimura, Toshihiro
    Tatani, Kazuya
    Katsuno, Kenji
    Fujimori, Yoshikazu
    Watanabe, Shinjiro
    Hiratochi, Masahiro
    Nakabayashi, Takeshi
    Kamada, Noboru
    Arakawa, Koichi
    Hikawa, Hidemasa
    Azumaya, Isao
    Isaji, Masayuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 34
  • [39] Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase Inhibitor
    Fischer, Thomas
    Riedl, Rainer
    CHEMISTRYOPEN, 2017, 6 (02): : 192 - 195
  • [40] The novel orally available sub-nanomolar potent and selective checkpoint kinase 1 inhibitor CASC-578 is highly active in mantle cell lymphoma as a single agent and in combination with Wee1 inhibition
    Rosler, Robert
    Taylor, Janelle
    Leviten, Dina
    Sierra, Teresa
    Dozier, Ashley
    Klucher, Kevin
    Boyce, Rich
    Boyle, Bob
    Vo, Alex
    Peterson, Scott
    CANCER RESEARCH, 2017, 77